Navigation Links
Accumetrics, Inc. Announces United Kingdom Distribution Agreement With ELITech UK Limited
Date:4/23/2009

SAN DIEGO, April 23 /PRNewswire/ -- Accumetrics, Inc. announces today an exclusive distribution agreement with ELITech UK Limited for distribution of the VerifyNow System in the United Kingdom. The distribution agreement marks the beginning of several new distribution channels for the Company as it expands its reach both in scope and geography. ELITech UK will concentrate its efforts on reaching customers in surgery suites and catheterization labs within UK hospitals and other medical centers.

"We are very pleased to have ELITech UK become our exclusive UK distributor. Their demonstrated expertise in this market and knowledge of our customer base in the UK will help expedite physician access to our products," said Timothy I. Still, President and CEO of the Company. "This partnership marks the beginning of our distribution channel expansion outside the U.S. and demonstrates our focus on rapidly growing our global presence."

"Distribution of the VerifyNow System is extremely complementary to our current portfolio of products, and we are delighted to add them among our customers," said Tim Watson, Managing Director of ELITech UK. "The VerifyNow System is an excellent fit with our expertise within the interventional cardiology market, and we look forward to a long and prosperous partnership with Accumetrics."

About Accumetrics (www.accumetrics.com)

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, prasugrel, Plavix(R), ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc., ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of Sanofi-Aventis.

About ELITech UK Limited (www.elitechuk.com)

Founded in 2000 ELITech UK Limited is a wholly owned subsidiary of the Pan European marketing and distribution company ELITech Group based in France. The ELITech Group (www.elitechgroup.com) is now a 60 million Euro in vitro diagnostic company with global sales and distribution capabilities in over 100 countries. ELITech offers clinical chemistry, microbiology, immunology and electrophoresis products and operates globally, leveraging products from its own biochemistry and microbiology equipment and reagents manufacturing facilities as well as third party products. In May 2007 ELITech acquired Wescor Inc, Utah USA to broaden its biomedical products platform and to provide a base for business expansion in the USA. In October 2007, ELITech acquired Vital Scientific in the Netherlands to allow the company to offer a complete biochemistry offering.

    CONTACT:
    Jules Abraham
    Lippert/Heilshorn & Associates
    212-838-3777
    jabraham@lhai.com

    Timothy I. Still
    President and CEO
    Accumetrics
    858-404-8260
    press@accumetrics.com


'/>"/>
SOURCE Accumetrics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D
2. Ad de Waard Appointed Vice President of International Sales and Marketing at Accumetrics, Inc.
3. Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... ... developing an ANSI-approved, consensus-based American National Standard for Good Manufacturing Practices (GMPs) ... first ANSI-approved GMP standard for dietary supplements this spring, is hiring an ...
(Date:3/29/2017)... CT (PRWEB) , ... March 29, 2017 , ... HealthCareMandA.com ... —on Thursday, April 20, 2017, at 1:00 PM ET. A recording of the webinar ... the Interactive Webinar Series. , Home health and hospice companies are still popular targets ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... Oncology™ (SOGO™), a specialized continuing medical education conference for clinicians who manage some ... Time Square, New York. , The program will be led by co- ...
(Date:3/28/2017)... ... March 28, 2017 , ... Tuesday, March 28, 2017, is the annual American ... Diabetes Risk Test to find out if they are at risk for developing Type ... up the evening sky by programming the LAX pylons the color red. Downtown’s U.S. ...
(Date:3/28/2017)... DC (PRWEB) , ... March 28, 2017 , ... ... on elected representatives in state legislatures and Congress to protect parental rights and ... public health and safety in America. , The demonstration coincides with a press ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... The global emerging cancer diagnostics market is ... 2016 to 2023 and reach a figure of $6.34 ... a chronic disease and is affecting a huge population. ... This report is focused on emerging cancer diagnostics market ... propelled due to factors such as: increasing number of ...
(Date:3/28/2017)... 28, 2017  Medeon Biodesign, Inc., a ... pleased to announce that the Company led and ... Orthopedics, Inc., a San Jose, CA ... for orthopedic extremity applications.  The ... primarily due to procedure volume growth, lifestyle influences ...
(Date:3/28/2017)... 28, 2017  "US Cancer Generics Market Outlook ... indicators and trend analysis related to the emergence ... pharmaceutical market in US. The report analyzes various ... on cancer generics drugs in recent years. The ... billions of dollars for various stake holders involved ...
Breaking Medicine Technology: